Research ArticleArticle
Molecular Mechanisms of Chloroquine Inhibition of Heterologously Expressed Kir6.2/SUR2A Channels
Daniela Ponce-Balbuena, Aldo A. Rodríguez-Menchaca, Angélica López-Izquierdo, Tania Ferrer, Harley T. Kurata, Colin G. Nichols and José A. Sánchez-Chapula
Molecular Pharmacology November 2012, 82 (5) 803-813; DOI: https://doi.org/10.1124/mol.112.079152
Daniela Ponce-Balbuena
“Unidad de Investigación Carlos Méndez” del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (D.P.-B., A.L.-I., T.F., J.A.S.-C.); Departamento de Fisiología de la Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México (A.A.R.-M.); Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (H.T.K.); and Cell Biology and Physiology, Center for the Investigation of Membrane Excitability Disorders, Washington University School of Medicine, St. Louis, Missouri (C.G.N.)
Aldo A. Rodríguez-Menchaca
“Unidad de Investigación Carlos Méndez” del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (D.P.-B., A.L.-I., T.F., J.A.S.-C.); Departamento de Fisiología de la Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México (A.A.R.-M.); Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (H.T.K.); and Cell Biology and Physiology, Center for the Investigation of Membrane Excitability Disorders, Washington University School of Medicine, St. Louis, Missouri (C.G.N.)
Angélica López-Izquierdo
“Unidad de Investigación Carlos Méndez” del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (D.P.-B., A.L.-I., T.F., J.A.S.-C.); Departamento de Fisiología de la Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México (A.A.R.-M.); Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (H.T.K.); and Cell Biology and Physiology, Center for the Investigation of Membrane Excitability Disorders, Washington University School of Medicine, St. Louis, Missouri (C.G.N.)
Tania Ferrer
“Unidad de Investigación Carlos Méndez” del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (D.P.-B., A.L.-I., T.F., J.A.S.-C.); Departamento de Fisiología de la Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México (A.A.R.-M.); Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (H.T.K.); and Cell Biology and Physiology, Center for the Investigation of Membrane Excitability Disorders, Washington University School of Medicine, St. Louis, Missouri (C.G.N.)
Harley T. Kurata
“Unidad de Investigación Carlos Méndez” del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (D.P.-B., A.L.-I., T.F., J.A.S.-C.); Departamento de Fisiología de la Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México (A.A.R.-M.); Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (H.T.K.); and Cell Biology and Physiology, Center for the Investigation of Membrane Excitability Disorders, Washington University School of Medicine, St. Louis, Missouri (C.G.N.)
Colin G. Nichols
“Unidad de Investigación Carlos Méndez” del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (D.P.-B., A.L.-I., T.F., J.A.S.-C.); Departamento de Fisiología de la Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México (A.A.R.-M.); Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (H.T.K.); and Cell Biology and Physiology, Center for the Investigation of Membrane Excitability Disorders, Washington University School of Medicine, St. Louis, Missouri (C.G.N.)
José A. Sánchez-Chapula
“Unidad de Investigación Carlos Méndez” del Centro Universitario de Investigaciones Biomédicas de la Universidad de Colima, Colima, México (D.P.-B., A.L.-I., T.F., J.A.S.-C.); Departamento de Fisiología de la Facultad de Medicina de la Universidad Autónoma de San Luis Potosí, San Luis Potosí, México (A.A.R.-M.); Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada (H.T.K.); and Cell Biology and Physiology, Center for the Investigation of Membrane Excitability Disorders, Washington University School of Medicine, St. Louis, Missouri (C.G.N.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
IKATP (Kir6.2/SUR2A) Channel Inhibition by Chloroquine
Daniela Ponce-Balbuena, Aldo A. Rodríguez-Menchaca, Angélica López-Izquierdo, Tania Ferrer, Harley T. Kurata, Colin G. Nichols and José A. Sánchez-Chapula
Molecular Pharmacology November 1, 2012, 82 (5) 803-813; DOI: https://doi.org/10.1124/mol.112.079152
Research ArticleArticle
IKATP (Kir6.2/SUR2A) Channel Inhibition by Chloroquine
Daniela Ponce-Balbuena, Aldo A. Rodríguez-Menchaca, Angélica López-Izquierdo, Tania Ferrer, Harley T. Kurata, Colin G. Nichols and José A. Sánchez-Chapula
Molecular Pharmacology November 1, 2012, 82 (5) 803-813; DOI: https://doi.org/10.1124/mol.112.079152
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement